BioCorRx (BICX) EBIT Margin Growth (5y) (2016 - 2026)
Analysis
BioCorRx (BICX) EBIT Margin Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 830,611.00 |
| Sep 30, 2025 | 658,042.00 |
| Jun 30, 2025 | 560,001.00 |
| Mar 31, 2025 | 341,818.00 |
| Jun 30, 2024 | -3.14 Mn |
| Mar 31, 2024 | -2.45 Mn |
| Dec 31, 2023 | -58,124.00 |
| Sep 30, 2023 | -769,825.00 |
| Jun 30, 2023 | -407,110.00 |
| Mar 31, 2023 | -224,709.00 |
| Dec 31, 2022 | -80,722.00 |
| Sep 30, 2022 | -64,006.00 |
| Jun 30, 2022 | -811,505.00 |
| Mar 31, 2022 | -517,420.00 |
| Dec 31, 2021 | -899,875.00 |
| Sep 30, 2021 | -1.82 Mn |
| Jun 30, 2021 | -590,991.00 |
| Mar 31, 2021 | -1.55 Mn |
| Dec 31, 2020 | -700,283.00 |